Literature DB >> 7100030

Altered quinidine disposition in a patient with chronic active hepatitis.

J R Powell, R Okada, K A Conrad, T W Guentert, S Riegelman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7100030      PMCID: PMC2426285          DOI: 10.1136/pgmj.58.676.82

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  The protein binding of some drugs in plasma from patients with alcoholic liver disease.

Authors:  M Affrime; M M Reidenberg
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

2.  Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.

Authors:  Y W Chien; H J Lambert; A Karim
Journal:  J Pharm Sci       Date:  1974-12       Impact factor: 3.534

3.  Disposition kinetics of quinidine.

Authors:  C T Ueda; D S Hirschfeld; M M Scheinman; M Rowland; B J Williamson; B S Dzindzio
Journal:  Clin Pharmacol Ther       Date:  1976-01       Impact factor: 6.875

4.  Pharmacokinetic studies of quinidine in patients with arrhythmias.

Authors:  K A Conrad; B L Molk; C A Chidsey
Journal:  Circulation       Date:  1977-01       Impact factor: 29.690

5.  Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias.

Authors:  R E Kates; T D Sokoloski; T J Comstock
Journal:  Clin Pharmacol Ther       Date:  1978-01       Impact factor: 6.875

6.  Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency.

Authors:  M Pérez-Mateo; S Erill
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

  6 in total
  2 in total

Review 1.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 2.  Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.

Authors:  J L Bauman; M D Schoen; T J Hoon
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.